TrialHaematologica2017

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study.

Anne-Laure Gagez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.